$4.72 +0.24 (5.36%) Ariad Pharmaceuticals Inc - NASDAQ

Feb. 12, 2016 | 04:00 PM
Key Statistics
Last Trade: 4.72
Trade Time: Feb 12 04:00 PM Eastern Daylight Time
Change: +0.24 (5.36%)
Prev Close: 4.48
Open: 4.53
Bid: 4.71
Ask: 4.72

Competitors

Ticker Name Volume % Change
GILD Gilead Sciences Inc 11.25M +2.38%
NVAX Novavax Inc 6.21M +1.77%
AMGN Amgen Inc 3.19M +2.30%
MDVN Medivation Inc 3.17M +6.51%
HALO Halozyme Therapeutics Inc 2.36M +1.48%

ARIA Stock Analysis

  1. No results found.

Partner Headlines

  1. Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial

    Benzinga | Feb. 1, 2016 | 14:49PM EST
  2. Benzinga's Top Initiations

    Benzinga | Jan. 19, 2016 | 09:55AM EST
  3. ARIAD Elects of Alex Denner as Chairman of the Board of Directors

    Benzinga | Jan. 10, 2016 | 18:30PM EST
  4. Mid-Morning Market Update: Markets Open Lower; Dow Chemical And DuPont Announce Merger

    Benzinga | Dec. 11, 2015 | 10:12AM EST
  5. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2015 | 08:27AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2015 | 08:20AM EST